INSPIREMD INC (NSPR) Stock Price & Overview
NASDAQ:NSPR • US45779A8466
Current stock price
The current stock price of NSPR is 1.39 USD. Today NSPR is down by -6.71%. In the past month the price decreased by -15.76%. In the past year, price decreased by -45.7%.
NSPR Key Statistics
- Market Cap
- 58.894M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.79
- Dividend Yield
- N/A
NSPR Stock Performance
NSPR Stock Chart
NSPR Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NSPR. When comparing the yearly performance of all stocks, NSPR is a bad performer in the overall market: 90.11% of all stocks are doing better.
NSPR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NSPR. NSPR has a great financial health rating, but its profitability evaluates not so good.
NSPR Earnings
On March 18, 2026 NSPR reported an EPS of -0.14 and a revenue of 3.15M. The company beat EPS expectations (29% surprise) and beat revenue expectations (17.59% surprise).
NSPR Forecast & Estimates
9 analysts have analysed NSPR and the average price target is 5.1 USD. This implies a price increase of 266.91% is expected in the next year compared to the current price of 1.39.
For the next year, analysts expect an EPS growth of -2% and a revenue growth 64.65% for NSPR
NSPR Groups
Sector & Classification
NSPR Financial Highlights
Over the last trailing twelve months NSPR reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS decreased by -1.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -58.87% | ||
| ROE | -72.05% | ||
| Debt/Equity | 0 |
NSPR Ownership
NSPR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 28.89 | 57.645B | ||
| COO | COOPER COS INC/THE | 13.93 | 13.714B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.5 | 12.251B | ||
| SOLV | SOLVENTUM CORP | 9.51 | 10.973B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.46 | 4.903B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.27 | 4.03B | ||
| ICUI | ICU MEDICAL INC | 14.48 | 3.037B | ||
| HAE | HAEMONETICS CORP/MASS | 11.08 | 2.717B | ||
| XRAY | DENTSPLY SIRONA INC | 7.86 | 2.325B | ||
| NEOG | NEOGEN CORP | 29.43 | 2.08B | ||
| UFPT | UFP TECHNOLOGIES INC | 18.51 | 1.48B | ||
| STAA | STAAR SURGICAL CO | 149.21 | 1.038B | ||
| BVS | BIOVENTUS INC - A | 11.32 | 750.013M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NSPR
Company Profile
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The company is headquartered in Miami, Florida and currently employs 85 full-time employees. The company went IPO on 2013-04-12. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
Company Info
IPO: 2013-04-12
INSPIREMD INC
6303 Waterford District Drive, Suite 215
Miami FLORIDA 6744832 US
CEO: Marvin Slosman
Employees: 85
Phone: 18887766804
INSPIREMD INC / NSPR FAQ
What does INSPIREMD INC do?
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The company is headquartered in Miami, Florida and currently employs 85 full-time employees. The company went IPO on 2013-04-12. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
What is the current price of NSPR stock?
The current stock price of NSPR is 1.39 USD. The price decreased by -6.71% in the last trading session.
Does INSPIREMD INC pay dividends?
NSPR does not pay a dividend.
How is the ChartMill rating for INSPIREMD INC?
NSPR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How many employees does INSPIREMD INC have?
INSPIREMD INC (NSPR) currently has 85 employees.
What is the next earnings date for NSPR stock?
INSPIREMD INC (NSPR) will report earnings on 2026-05-07.
What is the ownership structure of INSPIREMD INC (NSPR)?
You can find the ownership structure of INSPIREMD INC (NSPR) on the Ownership tab.